Drug intelligence / Profile preview

Zhoabex SOFT TOUCH

Development stage: Unknown
Lead developer: Rose Pharma
Administration: Intradermal

Overview

Zhoabex SOFT TOUCH is an injectable dermal filler developed and marketed by Homa Pharmed. It is part of a specialized range of hyaluronic acid-based fillers designed for aesthetic soft-tissue augmentation. The SOFT TOUCH variant is specifically formulated for the correction of superficial wrinkles and fine lines, as well as for subtle volume enhancement in delicate areas of the face. The product functions by physically occupying space within the dermal layers and retaining moisture, thereby smoothing the skin's surface and restoring youthful contours. It is provided as a sterile, cross-linked hyaluronic acid gel for intradermal injection.

Brand names: Zhoabex SOFT TOUCH
Other names: Zhoabex

Beyond the preview

Go deeper on Zhoabex SOFT TOUCH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhoabex SOFT TOUCH.

Explore the full profile